LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Tianlong Contributes to China’s Power to Prevent and Control Global Epidemics

By LabMedica International staff writers
Posted on 02 Jan 2023
Image: Tianlong exports its products to more than 100 countries and regions worldwide (Photo courtesy of Tianlong)
Image: Tianlong exports its products to more than 100 countries and regions worldwide (Photo courtesy of Tianlong)

Since the year 2003, Tianlong Science and Technology (Shaanxi, China) has witnessed several health crises globally and has also contributed to China’s power to prevent and control major epidemics such as COVID-19, SARS, Avian influenza, Ebola, Zika, and African swine fever.

Tianlong is an innovative high-tech company specializing in molecular diagnostic products. Since being founded in 1997, Tianlong has devoted itself to providing integrated PCR lab solutions for professionals worldwide. The company has a wide range of products from devices to reagents, including nucleic acid extractors, real-time PCR systems, all-in-one molecular diagnosis systems, sample processing systems, liquid handling systems, and 300 kinds of compatible reagents.

With NMPA, CE, and FDA marks, Tianlong’s products are exported to more than 100 countries and regions worldwide, and have greatly helped in the prevention and control of epidemics such as COVID-19, SARS, Avian influenza, Ebola, Zika, and African swine fever. Tianlong continues to excel in R&D and bringing technology to life to make people's lives healthier and happier.

Related Links:
Tianlong Science and Technology

Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
Automatic Hematology Analyzer
DH-800 Series

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more